PROK Stock Summary and Trading Ideas (Prokidney Corp. - Class A | NASDAQ:PROK)

ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

Prokidney Corp. - Class A trades on the NASDAQ stock market under the symbol PROK.

As of September 17, 2026, PROK stock price declined to $1.80 with 1,042,249 million shares trading.

PROK has a beta of 2.05, meaning it tends to be more sensitive to market movements. PROK has a correlation of 0.13 to the broad based SPY ETF.

PROK has a market cap of $376.07 million. This is considered a Small Cap stock.

Last quarter Prokidney Corp. - Class A reported $150,000 in Revenue and -$.15 earnings per share. This fell short of revenue expectation by $-13,200 and missed earnings estimates by -$.01.

In the last 3 years, PROK traded as high as $7.13 and as low as $.46.

The top ETF exchange traded funds that PROK belongs to (by Net Assets): IWM, VXF, SCHA, IWO, VTWO.

PROK has underperformed the market in the last year with a price return of -31.3% while the SPY ETF gained +16.7%. However, in the short term, PROK had mixed performance relative to the market. It has outperformed in the last 3 months, returning +6.5% vs +1.9% return in SPY. But in the last 2 weeks, PROK shares have been beat by the market, returning -5.8% compared to an SPY return of -0.3%.

PROK support price is $1.76 and resistance is $1.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PROK shares will trade within this expected range on the day.